ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA Approves Stiolto Respimat sNDA to Add Data on COPD Exacerbation Reduction
October 12, 2018Boehringer Ingelheim announced the U.S. Food and Drug Administration (FDA) approved new labeling for Stiolto Respimat (tiotropium bromide & olodaterol) Inhalation Spray that includes data showing a meaningful reduction in COPD exacerbations driven by tiot
Pharma Sources Insight January 2025
